ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Direxion Daily Biotech Top 5 Bull 2X ETF
38.36
-0.5386
-1.38%
盤後：
38.53
0.1700
+0.44%
16:10 EDT
成交量：
7,280
成交額：
28.42萬
市值：
287.70萬
市盈率：
- -
高：
39.06
開：
39.06
低：
38.36
收：
38.90
52周最高：
45.88
52周最低：
25.71
股本：
7.50萬
流通股本：
7.50萬
量比：
0.49
換手率：
9.71%
股息：
0.62
股息率：
1.62%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
瑞穗上調安進目標價至352美元
格隆汇
·
08/19
藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」
蓝鲸财经
·
08/19
TScan Therapeutics披露：安進將終止與其研究合作及許可協議
美股速递
·
08/19
吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光
TradingKey中文
·
08/19
深圳易慕峯生物科技股份有限公司向港交所提交IPO申請，華泰金融控股（香港）為保薦人兼整體協調人。
格隆汇
·
08/18
argenx SE(ARGX)股票8月17日盤中上漲16.67%：關鍵驅動因素揭曉
TradingKey中文
·
08/18
EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標
路透中文
·
08/17
美股開盤 | 三大指數升跌不一，閃迪升逾3%，Argenx SE漲近9%
老虎资讯综合
·
08/17
EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗，股價暴跌
路透中文
·
08/17
美股異動 | Argenx(ARGX.US)盤前升逾10% 自身免疫性肌炎藥物Vyvgart III期研究達主要終點
智通财经
·
08/17
美股異動丨Argenx SE盤前大升逾7%，Efgartigimod治療肌炎III期試驗成功
中金财经
·
08/17
步長製藥：控股子公司藥品臨床試驗申請獲受理，研發投入約3175.45萬元
智通财经
·
08/17
argenx SE（ARGX）宣佈Efgartigimod治療自身免疫性肌炎的3期ALKIVIA試驗取得積極結果
金吾财讯
·
08/17
巴克萊上調安進目標價至380美元
格隆汇
·
08/17
Assembly股價上漲，因季度營收超出預期
路透中文
·
08/14
MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項
路透中文
·
08/12
數據簡報-全球製藥企業斥資數十億以擴大在美業務
路透中文
·
08/11
Tango因季度虧損額超出預期而股價下跌
路透中文
·
08/11
百濟神州（06160）盤初漲3.94% 與安進聯合開發及商業化的安泰適正式投入臨床使用
金吾财讯
·
08/11
美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%
智通财经
·
08/10
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TBXU/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.3601,"timestamp":1789156800000,"preClose":38.8987,"halted":0,"volume":7280,"hourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"delay":0,"changeRate":-0.01384622108193835,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"未開盤","change":-0.5386,"latestTime":"09-11 16:00:00 EDT","open":39.06,"high":39.06,"low":38.3601,"amount":284204,"amplitude":0.017993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.8987,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01621,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"volumeRatio":0.4910292679310407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4910292679310407,"shares":75001,"dividePrice":0.6218,"high":39.06,"amplitude":0.017993,"preClose":38.8987,"low":38.3601,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.3601,"eps":0,"divideRate":0.01621,"volume":7280,"delay":0,"ttmEps":0,"open":39.06,"prevYearClose":31.065,"prevWeekClose":44.3833,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":45.76,"twentyDayClose":38.3309,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4534","IBBQ","LU0109394709.USD","LU0058720904.USD","PBE","LU0889565916.HKD","UDN","LU0122379950.USD","LU2089984988.USD","BBH","BK4585","LU0289739699.SGD","BK4581","IE0009355771.USD","LU1983299246.USD","IBB","LU1057294990.SGD","LU1061106388.HKD","BK4139","UUP","IE00B4R5TH58.HKD","PJP","LU2112291526.USD","LU1571399168.USD","LU2242646821.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0868494617.USD","BK4533","IE00B2B36J28.USD","BK4588","LU2242652126.USD","SG9999001440.SGD","BK4599","TBXU","IE0002141913.USD","AMGN","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IE0009355771.USD","BIB","PJP","TBXU","LU1023059063.AUD","BK4585","LU0889565916.HKD","BK4581","LU2089984988.USD","IE00B4R5TH58.HKD","IBB","IBBQ","LU0320765992.SGD","LU0289739699.SGD","LU2468319806.SGD","PBE","LU2242652126.USD","BK4588","BK4139","688578","IE00BFTCPJ56.SGD","AMGN","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2112291526.USD","BBH","LU1571399168.USD","LU0868494617.USD","LU1057294990.SGD","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE0002141913.USD","BK4566","BK0239","SG9999001440.SGD","LU0122379950.USD","LU2242646821.SGD","BK4599","LU0109394709.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0868494617.USD","BK4585","LU0889565916.HKD","IE0002141913.USD","BK4539","LU1983299246.USD","BIB","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2242646821.SGD","BK4588","LU2242652126.USD","LU2089984988.USD","BK4581","IE00B2B36J28.USD","LU0058720904.USD","SG9999001440.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4566","BK4599","LU1061106388.HKD","BK4534","LU0109394709.USD","IE00BFTCPJ56.SGD","TCRX","PBE","BK4533","PJP","LU2112291526.USD","LU0320765992.SGD","IBB","IE00BJT1NW94.SGD","BBH","BK4139","TBXU","LU0289739699.SGD","LU1571399168.USD","IE0009355771.USD","IBBQ","LU0122379950.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491619","title":"吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491619","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 02:16","pubTimestamp":1787076999,"startTime":"0","endTime":"0","summary":"• 联邦法院禁令阻止了吉利德关键HIV药物的海外进口。\n• 强劲的基础业务营收增长与上调业绩指引提振了市场乐观情绪。\n• 肿瘤领域的战略投资及机构看涨期权活动的活跃支撑了股价的上涨势头。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262115765-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IBB","MEDI","SG9999015952.SGD","GILD","LU1061106388.HKD","LU1934455863.HKD","BK4532","LU1023059063.AUD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0965509101.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","BK4583","LU1037948897.HKD","TBXU","LU0320765992.SGD","LU1430594728.SGD","LU0289739699.SGD","LU0109394709.USD","LU1037948541.HKD","SG9999015978.USD","IE00B19Z3581.USD","SG9999015986.USD","BMED","LU0114720955.EUR","BK4585","LU1066053197.SGD","LU1778281490.HKD","IE00BZ1G4Q59.USD","BK4566","LU1674673428.USD","IE00B3T34201.USD","LU2112291526.USD","LU1674673691.USD","BK4578","LU2089984988.USD","BIB","LU0823416689.USD","IBBQ","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1839511570.USD","LU1571399168.USD","BBH","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660304824","title":"深圳易慕峯生物科技股份有限公司向港交所提交IPO申請，華泰金融控股（香港）為保薦人兼整體協調人。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660304824","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660304824?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 07:26","pubTimestamp":1787009193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["REDS","KCE","FRHC","159940","IPOS","TBXU","BK4127","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439442","title":"argenx SE(ARGX)股票8月17日盤中上漲16.67%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439442","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439442?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:16","pubTimestamp":1786983373,"startTime":"0","endTime":"0","summary":"• Argenx 宣布其药物 VYVGART Hytrulo 在治疗肌炎的 3 期 ALKIVIA 研究中取得积极结果。\n• 该公司公布全年营收为 41.5 亿美元，净利润为 12.9 亿美元。\n• 分析师给予“买入”评级，平均目标价为 1083.77 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262112725-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0109394709.USD","FMED","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4585","LU1983260115.SGD","IE0034235188.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2324357040.USD","IE0002141913.USD","IE00B2B36J28.USD","IBB","BK4505","LU0823416689.USD","IE00B4R5TH58.HKD","BK4588","ARGX","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332334","title":"EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332334","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332334?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 22:15","pubTimestamp":1786976114,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标最新动态8月17日-**EyePoint公司（EYPT.O）股价暴跌71%至4.17美元，有望创下有史以来最大单日跌幅，并跌至2025年4月以来的最低点**这家药物开发商表示，其实验性眼科药物Duravyu在针对湿性年龄相关性黄斑变性（视力丧失的主要原因之一）患者开展的晚期临床试验中，未能达到主要目标","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU2106854487.HKD","BK4007","LU2362541273.HKD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","LU2237438978.USD","LU1974910355.USD","BK4588","IBB","EYPT","LU0320765992.SGD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU2362541513.USD","LU0053666078.USD","TBXU","LU0114720955.EUR","LU0823416689.USD","LU2362540622.SGD","LU0823434583.USD","BK4139","BBH","IBBQ","REGN","LU1917777945.USD","LU0882574055.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137019504","title":"美股開盤 | 三大指數升跌不一，閃迪升逾3%，Argenx SE漲近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137019504","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137019504?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:32","pubTimestamp":1786973544,"startTime":"0","endTime":"0","summary":"8月17日，美股三大指数开盘涨跌不一，道琼斯指数跌0.23%，标普500指数涨0.04%，纳斯达克综合指数涨0.24%。美股存储股普涨，SK海力士、西部数据、闪迪涨超3%，美光科技、希捷科技涨超2%。OmniAb涨超23%，公司此前宣布与礼来达成3.7亿美元药物研发协议。Argenx SE涨近9%，Efgartigimod治疗肌炎III期试验成功。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WUGI","LU0476273544.USD","MEDX","LU2756315664.SGD","SGXZ51526630.SGD","SKHZ","LU0820561818.USD","SKUU","IE00BFSS8Q28.SGD","LU1267930730.SGD","LU2361044949.HKD","FXL","LU0823434740.USD",".DJI","LU0889565916.HKD","LU1914381329.SGD","LU1127390331.HKD","ILDR","QQQA","IHE","DDM","BOBP","LU2286300806.USD","LU2168564149.EUR","IE0009356076.USD","LU0444973449.USD","LU1815336760.USD","WLDR","BK4543","LU1917777945.USD","TMSL","LU2360106780.USD","IE00BWXC8680.SGD","GDOC","IE0001KFT4U8.USD","VOO","LU0210536198.USD","LU1064131342.USD","LU0432979614.USD","LU2089284900.SGD","LU1145028129.USD","LU0133085943.USD","SNDK","BK4007","LU2746668461.USD","CURE","BK4516","BK4554","LU1674673428.USD","THNR","BK7142","CANC","CHAT","IE0004445239.USD","LU2054465674.USD","IE00B19Z9Z06.USD","CHPS","LU1868836591.USD","DOG","LU0127658192.USD","LU2491050154.USD","LU2112291526.USD","SG9999013999.USD","FAI","VHT","LU0320765992.SGD","LU0859254822.USD","LU0882574139.USD","LU0203347892.USD","LU1674673691.USD","LU2063271972.USD","SG9999001176.SGD","IE00BSNM7G36.USD","BK4512","SG9999014898.SGD","LU0345770308.USD","BK4588","LU0256863811.USD","LU0889566641.SGD","LU0820561909.HKD","LU2468319806.SGD","SG9999014880.SGD","LU1235294995.USD",".SPX","LU0787776722.HKD","DMAX","LU0240877869.USD","SPYU","LU2111349929.HKD","MUD","LU1974910355.USD","SG9999018857.SGD","WDNA","LU0792757196.USD","LU2168564065.EUR","BK4139","LU2491050071.SGD","LU2471134952.CNY","CGGO","LU1035773651.USD","LU2168563687.JPY","LU0316494557.USD","IE00B19Z3581.USD","LU2237443465.HKD","UDOW","IVV","LU2462157665.USD","LU2896262040.SGD","LU0109394709.USD","SG9999015986.USD","BK4141","LU1814569148.SGD","LU2360107168.USD","LU0640476718.USD","IE0002141913.USD","LU2236285917.USD","LU0198837287.USD","ELIL","LU1979441026.SGD","IE00B894F039.SGD","LU2237443978.SGD","LU0158827781.USD","LU0082616367.USD","JGRO","MUZ","PTF","IE00BJJMRY28.SGD","LU2458330169.SGD","FTXH","LU2237443382.USD","LU0353189680.USD","LU0174119429.USD","LU2108987350.USD","IE00BJJMRX11.SGD","SDS","LU1267930813.SGD","LU0158827948.USD","SPDN","IE0009355771.USD","LU0274383776.USD","FDTX","EGGY","LU1629891620.HKD","IE00BJT1NW94.SGD","SNDG","SG9999017495.SGD","SG9999014906.USD","JDOC","BK4532","IE00B4JS1V06.HKD","TMED","LU1280957306.USD","LU1023059063.AUD","BK4605","XNTK","LU0719512351.SGD","HYNX","YSPY","STX.AU","LU2237443895.HKD","BAI","IE00BN29S564.USD","LU0006061336.USD","SG9999001176.USD","LU2237438978.USD","WDC","LU1988902786.USD","LU1093756168.USD","LU0072461881.USD","LU2089985449.USD","FCUS","LU0964807845.USD","LU1868836757.USD","SKDD","LU0154236417.USD","LU1069344957.HKD","LU1720051017.SGD","LU0054578231.USD","SNDU","LLYZ","LU0203202063.USD","SPXU","TTXU","LU2750360641.GBP","DXD","LU1720051108.HKD","LU2048586759.USD","SG9999015945.SGD","LU0456855351.SGD","LU0006306889.USD","LU2471134523.USD","LU0471298777.SGD","IE0002270589.USD","IE00BKPKM429.USD","LU2552382132.HKD","SPYQ","SG9999001424.SGD","LEGR","LU0889565833.HKD","LU1861220033.SGD","LU2271345857.HKD","IE0034235188.USD","IE00BFTCPJ56.SGD","IE00BJLML261.HKD","IE00B5949003.HKD","LU2931357623.SGD","SSO","CNEQ","LU1323610961.USD","LU1989764748.USD","BK4579","LU0444971666.USD","SOXX","LU0943347566.SGD","LU2211815571.USD","IE00B7SZLL34.SGD","IE00BJJMRZ35.SGD","QQQG","GB00BDT5M118.USD","LU0096364046.USD","LU0122379950.USD","SG9999014914.USD","STX","LU0106261372.USD","SDOW","IE00B1BXHZ80.USD","FMED","PPH","LU2213496289.HKD","LU2746668974.SGD",".IXIC","SH","LU0266013472.USD","LU1989764664.SGD","PJP","LU2028103732.USD","MUU","LU1861215975.USD","OPTZ","TBXU","LU1551013425.SGD","SGXZ57979304.SGD","LU0353189763.USD","SPY","DRMY","SMH","SMU00main","AIFD","LU0786609619.USD","SCHA","MULL","LU2360106947.USD","ARGX","PSI","LU0323591593.USD","SG9999015978.USD","LU2290526834.HKD","YMmain","LU2023250330.USD","SOXQ","LU0256863902.USD","LU2250418816.HKD","LU1868837300.USD","ELIS","LU0385154629.USD","SNDC","IXN","BK4505","LU2361044865.SGD","LU1868836914.USD","SGXZ81514606.USD","LU2023250504.SGD","IETC","LU2102340556.USD","LU0823416689.USD","LU0162691827.USD","LU1057294990.SGD","AIS","LU1778281490.HKD","BK4553","LU0056508442.USD","LU2543165471.USD","DIA","LU1670627923.USD","BK4575","LU2168564222.USD","LU2168564495.EUR","LU1868837136.USD","LU0234572021.USD","DISK","IXJ","IE00B1XK9C88.USD","LU2458330243.SGD","SCHM","LU0240878834.USD","LU2461242641.AUD","LU0345770993.USD","LU1046421795.USD","LU0708995401.HKD","EFIV","IE00B7KXQ091.USD","LU1035775433.USD","LU2462591350.SGD","LLII","LU2106854487.HKD","IE00B4R5TH58.HKD","VGT","LU2750360997.AUD","XLK","LU2265009873.SGD","LU2357305700.SGD","AGNG","UPRO","IE00BK4W5L77.USD","TRFK","LU1670628061.USD","SGXZ99366536.SGD","LU0109392836.USD","LU1804176565.USD","OZEM","SK","TRUH","LU1366333091.USD","SKHYV","SPYH","SKHX","LU2089283258.USD","WDCX","IE0034235303.USD","LU2361045086.USD","LU1232071149.USD","SPYM","RXL","LU0820562030.AUD","LU0114720955.EUR","LU0689472784.USD","MIC","IE000M9KFDE8.USD","COWG","IE00BKDWB100.SGD","LU2087625088.SGD","IE00BK4W5M84.HKD","LU0203201768.USD","LU2456880835.USD","LU1803068979.SGD","LU0823434583.USD","IE00BFSS7M15.SGD","LU0097036916.USD","SG9999015952.SGD","FTXL","SPXS","LU1551013342.USD","LU0683600562.USD","AIQ","LU1823568750.SGD","FSMD","LU2602419157.SGD","LU0079474960.USD","LU0957808578.USD","LU2403377893.USD","SNDQ","LU0081259029.USD","BK4581","USXF","LU2023251221.USD","BK4585","LU0417517546.SGD","SKHA","HBMX","BK4566","LU0061475181.USD","IE0004445015.USD","LU1712237335.SGD","LU2089984988.USD","LLYX","IE00B19Z3B42.SGD","LU1061106388.HKD","SMAX","RULE","LU1989771016.USD","LU1548497426.USD","MEDI","LU1291159041.SGD","LU0882574055.USD","HIBL","LU1983260115.SGD","BK4533","CNAV","LU0203345920.USD","LU0354030511.USD","LU2417539215.USD","SHOC","LU2552382058.USD","LU0058720904.USD","MU","XLV","SG9999018865.SGD","LU0320765059.SGD","EMSF","IE0005OL40V9.USD","LU1852331112.SGD","LU2264538146.SGD","LU0289739699.SGD","FHLC","LLY","LU0471298694.HKD","MUYY","BK4534","LU0157215616.USD","IYH","LU2471134796.USD","SPUU","LU0642271901.SGD","LU0238689110.USD","BK4170","BK4599","LU0094547139.USD","MHIP","LU1642822529.SGD","LU2237443622.USD","LU1316542783.SGD","SKHU","LU1983299246.USD","LU0466842654.USD","IBB","ARTY","LU2552382215.SGD","FTEC","MMAX","LU2756315318.SGD","LU1366192091.USD","LU0354030438.USD","LU0225283273.USD","LU1069347547.HKD","SKHY","BK4527","IE00B2B36J28.USD","LU2491049909.HKD","SNXX","LU2357627491.SGD","IE00B19Z9P08.USD","SGXZ31699556.SGD","HRTS","LU1093756325.SGD","SPXL","LU0109391861.USD","IE00B775H168.HKD","LU1623119135.USD","LU2471134879.HKD","CHPX","LU2324357040.USD","LU0963586101.USD","07709","LU2237443549.SGD","LU0672654240.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848445","title":"EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗，股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848445","media":"路透中文","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848445?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:14","pubTimestamp":1786965255,"startTime":"0","endTime":"0","summary":"EyePoint公司未能证明Duravyu在保护视力方面不比Eylea明显逊色。而在接受Eylea治疗的患者中，未出现此类情况。EyePoint的股价在早盘交易中跌至4.16美元。EyePoint计划于2027年上半年向美国FDA提交批准申请，具体取决于预计于今年晚些时候公布的第二项晚期临床试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0058720904.USD","LU0823434583.USD","LU0114720955.EUR","IBB","LU0289739699.SGD","TBXU","LU2089984988.USD","IBBQ","BBH","BK4588","LU1917777945.USD","LU0889565916.HKD","LU0823416689.USD","LU2106854487.HKD","REGN","LU1974910355.USD","LU0109394709.USD","EYPT","LU2362541513.USD","LU2362541273.HKD","LU0053666078.USD","LU0823434740.USD","BK4585","LU2237438978.USD","LU2468319806.SGD","BK4139","BK4007","LU2023250504.SGD","LU2362540622.SGD","OTLK","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481020","title":"美股異動 | Argenx(ARGX.US)盤前升逾10% 自身免疫性肌炎藥物Vyvgart III期研究達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:48","pubTimestamp":1786963699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ARGX","TBXU","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0889565916.HKD","BK4134","IE00BFTCPJ56.SGD","FMED","LU1983260115.SGD","BK4588","IE0034235188.USD","BK4585","IE00BJJMRZ35.SGD","IBB","LU0823416689.USD","IE0002141913.USD","BK4139","LU0320765992.SGD","III","IE00B4R5TH58.HKD","IE0009355771.USD","LU2324357040.USD","BK4505","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848605","title":"美股異動丨Argenx SE盤前大升逾7%，Efgartigimod治療肌炎III期試驗成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848605","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848605?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:37","pubTimestamp":1786959424,"startTime":"0","endTime":"0","summary":"Argenx SE(ARGX.US)盘前涨超7%，报913.38美元。消息面上，公司宣布，Efgartigimod在治疗自身免疫性肌炎的III期ALKIVIA试验中达到了主要终点。在52周时，与安慰剂相比，药物在总改善评分(TIS) 上实现了具有统计学和临床意义的改善。此次试验成功对Argenx意义重大，开辟新市场：自身免疫性肌炎在美国影响约10万人，其中IMNM约2万，DM约4万，这是一个尚未被满足的巨大医疗市场。公司计划为IMNM提交加速审批申请，并将与FDA讨论DM的申报可能性。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/17/20260817706794.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/17/20260817706794.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260817/32337291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE00BFTCPJ56.SGD","LU1983260115.SGD","BK4505","IE0002141913.USD","LU2324357040.USD","LU0889565916.HKD","FMED","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0034235188.USD","LU0823416689.USD","TBXU","LU0320765992.SGD","IE00B4R5TH58.HKD","BK4139","IBB","LU0109394709.USD","BK4134","BK4588","IE0009355771.USD","IE00BJT1NW94.SGD","ARGX","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660648687","title":"步長製藥：控股子公司藥品臨床試驗申請獲受理，研發投入約3175.45萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660648687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660648687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:16","pubTimestamp":1786958196,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","NVOH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660853994","title":"argenx SE（ARGX）宣佈Efgartigimod治療自身免疫性肌炎的3期ALKIVIA試驗取得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2660853994","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660853994?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 16:43","pubTimestamp":1786956188,"startTime":"0","endTime":"0","summary":"该试验评估了皮下注射药物VYVGART Hytrulo在成人自身免疫性肌炎中的疗效，包括免疫介导的坏死性肌病和皮肌炎。在IMNM亚组分析中，治疗组同样展现出14.8分的显著改善。这是全球首个在没有任何批准疗法的IMNM领域取得统计学显著与临床意义改善的三期临床试验。自身免疫性肌炎属于罕见且高度致残的疾病，长久以来临床严重依赖大剂量激素和广谱免疫抑制剂。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303846","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","IE0034235188.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4505","LU1983260115.SGD","BK4139","TBXU","IE00BJT1NW94.SGD","BK4585","BK4588","LU0823416689.USD","LU0320765992.SGD","IE0009355771.USD","IBB","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101358","title":"巴克萊上調安進目標價至380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101358?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:05","pubTimestamp":1786935953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0889565916.HKD","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","PBE","LU2112291526.USD","BK4533","LU0058720904.USD","LU2468319806.SGD","UUP","LU2089984988.USD","PJP","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","UDN","LU2242652126.USD","LU0289739699.SGD","LU0868494617.USD","LU1061106388.HKD","BK4581","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","BK4566","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","LU2242646821.SGD","BBH","BIB","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659400001","title":"Assembly股價上漲，因季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2659400001","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659400001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:25","pubTimestamp":1786721141,"startTime":"0","endTime":"0","summary":"BUZZ-Assembly股价上涨，因季度营收超出预期8月14日-** 药物研发公司Assembly Biosciences（ASMB.O）股价上涨4.6%，报31.32美元** ASMB第二季度与吉利德（GILD.O）合作研究的收入为1340万美元，高于去年同期的960万美元** 据LSEG数据显示，分析师此前平均预期营收为860万美元** 公司表示，营收增长包括针对吉利德合作项目下未来活动最新预估所作的510万美元补足调整** 报告显示第二季度每股亏损20美分，而市场预期为每股亏损65美分** 计入当日涨幅后，该股年初至今累计上涨11.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4S44B103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0965509283.SGD","ASMB","BK4585","LU0889565916.HKD","LU0114720955.EUR","BIB","BK4532","LU2468319806.SGD","TMED","BK4568","IE00BZ1G4Q59.USD","BK4588","LU1037948897.HKD","MEDI","BK4550","LU0058720904.USD","LU0965509101.SGD","LU1037948541.HKD","LU0861579265.USD","LU2087621335.USD","LU1066051498.USD","BK4566","IE00B19Z3581.USD","LU1061106388.HKD","LU1585245621.USD","LU1934455277.USD","SG9999015986.USD","BK4578","LU0109394709.USD","SG9999015945.SGD","BK4583","SG9999015952.SGD","LU2112291526.USD","IE00B3T34201.USD","IBB","GILD","LU1839511570.USD","IE00BSNM7G36.USD","BBH","LU0965508806.USD","LU1066053197.SGD","BK4139","LU2324357040.USD","TBXU","LU0289739699.SGD","LU0234570918.USD","IBBQ","LU0122379950.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658465479","title":"MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項","url":"https://stock-news.laohu8.com/highlight/detail?id=2658465479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658465479?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 05:18","pubTimestamp":1786483082,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics股价上涨，因吉利德支付了1000万美元的里程碑款项8月11日-** 药物开发商MacroGenics（MGNX.O）的股价在盘后交易中上涨3.8%，至4.07美元** 该公司表示，根据其与吉利德（GILD.O）就一项临床前双特异性项目（一种癌症疗法）达成的许可协议，已收到1000万美元的里程碑付款** 根据2022年签署的合作协议，MacroGenics与吉利德正在推进三个项目：处于临床阶段的抗癌疗法MGD024，以及两个处于临床前阶段的双特异性项目** MGNX仍有资格获得最高约16亿美元的额外开发、监管及商业里程碑付款** 今年以来，该公司股价已翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S4481IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","GILD","LU0965509101.SGD","LU1778281490.HKD","TMED","SG9999015945.SGD","SG9999015952.SGD","BK4550","IE00B7SZLL34.SGD","LU1585245621.USD","BK4566","BK4585","LU0234570918.USD","IE00B19Z3B42.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0965508806.USD","BBH","IE00BZ1G4Q59.USD","BMED","LU2087621335.USD","LU1430594728.SGD","LU2324357040.USD","BK4532","LU0882574055.USD","LU2089984988.USD","LU1839511570.USD","LU1934455277.USD","SG9999015986.USD","IBB","LU0114720955.EUR","BK4588","IBBQ","LU1674673428.USD","MEDI","TBXU","MGNX","LU1023059063.AUD","LU1066051498.USD","LU1934455863.HKD","BIB","BK4578","IE00B19Z3581.USD","LU0058720904.USD","BK4139","IE0002270589.USD","LU1674673691.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658591102","title":"數據簡報-全球製藥企業斥資數十億以擴大在美業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2658591102","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658591102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:59","pubTimestamp":1786463961,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美业务更新了第18段中关于百健生产工厂的数据路透8月11日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。这家制药公司宣布将投资 6.5 亿美元 ，以扩大其位于波多黎各洪科斯工厂的药品生产规模，此举预计将创造近 750 个就业岗位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S448167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","LU1941712348.USD","LU2491050071.SGD","LU1032466523.USD","GB00BDT5M118.USD","IE00B3T34201.USD","LU2129689514.USD","LU1506573853.SGD","BIIB","MHIP","LU0882574055.USD","LU1988902786.USD","SG9999015358.SGD","SGXZ99366536.SGD","MEDX","SG9999015952.SGD","IE0004445015.USD","LU1585245621.USD","LU2211815571.USD","LU0823434740.USD","LU0942090050.USD","BK4581","IE00B3PB1722.GBP","SG9999015978.USD","LU0124676726.USD","LU2023250330.USD","LU1629891620.HKD","SGXZ80539844.SGD","IE00BBT3K403.USD","LU0053666078.USD","LU2237438978.USD","LU0868494708.USD","LU1430594728.SGD","LU1974910355.USD","LU2430703251.USD","IE000MB6IJN5.SGD","LU2596442595.SGD","LU0980610538.SGD","LU1069344957.HKD","LU2491050154.USD","LU2089284900.SGD","IBB","BK4007","IE00BJJMRY28.SGD","LU2168564222.USD","IE00BK4W5L77.USD","LU0208291251.USD","LU0965509283.SGD","LU1868836591.USD","LU1917777945.USD","LU2357627491.SGD","LU2552382058.USD","LU1699723380.USD","LU0320765646.SGD","LU0820561909.HKD","LU2063271972.USD","LU2750360997.AUD","LU0057025933.USD","LU1064131342.USD","LU2491049909.HKD","LU0098860793.USD","LU1712237335.SGD","LU0256863902.USD","LU2360106947.USD","LU0210528500.USD","LU1116320901.HKD","BK4592","LU0079474960.USD","LU0238689110.USD","LU2111349929.HKD","LU0203345920.USD","LU0006306889.USD","LU0994945656.USD","LU0158827781.USD","LU2433249047.HKD","BK4559","SG9999013999.USD","LU1670711040.USD","LLYZ","LU1244550494.USD","SG9999011175.SGD","IE00B775H168.HKD","LU0432979614.USD","LU0477156953.USD","LU2456880835.USD","SG9999001176.USD","FHLC","IE00B19Z3581.USD","LU1267930730.SGD","LU2112291526.USD","LU0320765059.SGD","LU0786609619.USD","BK4532","LU1035775433.USD","LU1979441026.SGD","LU1496350502.SGD","IE00BKDWB100.SGD","IE0000B7K699.USD","LU0122379950.USD","LU1778281490.HKD","LU1366192091.USD","IE00BFXG1179.USD","LU2756315318.SGD","LU0237698245.USD","LU1720051108.HKD","LU1551013425.SGD","AMGN","BMED","IE00BJT1NW94.SGD","LU0672654240.SGD","LU1023059063.AUD","LU1983299246.USD","LU2264538146.SGD","LU1323610961.USD","LU0114720955.EUR","LU0456855351.SGD","LU0965509010.AUD","LU0211327993.USD","LU0321505439.SGD","LU2461242641.AUD","BK4533","LU0964807845.USD","IE00BZ1G4Q59.USD","SG9999014542.SGD","LU2347655073.USD","LU0738911758.USD","IE0002141913.USD","LU2237443622.USD","LU2265009873.SGD","LU0912757837.SGD","IE000F7OJYX1.SGD","TBXU","MEDI","LU0133085943.USD","LU0466842654.USD","LU2023250843.SGD","XLV","LU1934455194.USD","LU0320765489.SGD","LU0211328371.USD","IE0002270589.USD","LU2430703095.HKD","LU0106261372.USD","LU2756315664.SGD","LU2087625088.SGD","LU2125154935.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU0689626769.HKD","LU0203202063.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","PFE","HRTS","LU2552382215.SGD","LU1121112475.USD","LU0310799852.SGD","IE00BN8TJ469.HKD","IE0001KFT4U8.USD","LU1069347547.HKD","LU1894683348.USD","IE00BGHQF631.EUR","CURE","LU2357305700.SGD","IE00BDGV0183.EUR","LU0162691827.USD","IE00B42XCP33.USD","IE0005OL40V9.USD","SG9999015945.SGD","IBBQ","LU1221951129.SGD","LU0234570918.USD","LU1261432733.SGD","LU2505996681.GBP","IE00BLSP4239.USD","LU1674673691.USD","LU1267930573.SGD","SG9999014559.SGD","LU0661504455.SGD","LU1670628061.USD","LU1935042991.SGD","LU1670710588.SGD","LU2023250504.SGD","AZNH","TRUH","LU2468319806.SGD","SG9999002224.SGD","GLAM","IE00B19Z9Z06.USD","LU2242646821.SGD","BK4504","SG9999002232.USD","LU0345769128.USD","LU0265550359.USD","LU1623119135.USD","SGXZ51526630.SGD","LU1093756325.SGD","LU1232071149.USD","LU0868494617.USD","LU1228905037.USD","LU0225283273.USD","IE00BKVL7J92.USD","LU2746668461.USD","JDOC","LU0072461881.USD","BK7501","LU2168563687.JPY","LU2417539215.USD","BK4534","IE00B1XK9C88.USD","LU0820562030.AUD","LU1868836914.USD","SG9999015986.USD","LU1934455863.HKD","LU0882574139.USD","IE000WAW04H5.SGD","LU2125909247.SGD","LU2602419157.SGD","LU1127390331.HKD","LU0306807586.USD","LU1066051811.HKD","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1061106388.HKD","LU1066053197.SGD","VHT","LU1291159041.SGD","BK4566","LU1868836757.USD","LU0859254822.USD","LU1883839398.USD","BK4599","LU0471298694.HKD","GDOC","LU0708995401.HKD","TMED","LU2360032135.SGD","LU0385154629.USD","LU0726765562.USD","IE0034235303.USD","LU0795875086.SGD","LU2471134523.USD","LU0097036916.USD","IE00B19Z9P08.USD","IE000M9KFDE8.USD","WDNA","LU0426417589.USD","LU0708994859.HKD","LU2168564065.EUR","LU0058720904.USD","LU2125909593.SGD","LU2505996509.AUD","BK4139","LU1804176565.USD","SG9999003800.SGD","LLY","LU0395794307.EUR","LU2237443978.SGD","IE00BN29S564.USD","LU1280957306.USD","LU2129689605.HKD","SGXZ81514606.USD","LU1496350171.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU2168564495.EUR","FTXH","LU2213496289.HKD","LU1670710661.SGD","LU0417517546.SGD","LU0234572021.USD","PJP","LU0174119429.USD","LU0289739343.SGD","LU0128525929.USD","IE00BJLML261.HKD","LU0354030511.USD","LU2237443465.HKD","LU1548497426.USD","LU1923622614.USD","LU1868837136.USD","BIB","IE00B19Z3B42.SGD","LU0965509101.SGD","ELIS","BMY","IE00BVYPNW00.USD","LU1196500208.SGD","LU1043141396.HKD","LU2324357040.USD","IE00B2B36J28.USD","IE00B7KXQ091.USD","LU2361044949.HKD","RXL","CANC","LU0265550946.USD","IE00BFSS7M15.SGD","BK4568","AZN","LU1718418525.SGD","LU1941712264.USD","LU0861579265.USD","LU2237443549.SGD","LU0943347566.SGD","LU1057294990.SGD","LU0640476718.USD","LU1244550577.SGD","LU2087621335.USD","LU1732799900.SGD","IHE","LU2361045086.USD","LU1670627923.USD","LU1145028129.USD","LLII","LU0792757196.USD","LU0170899867.USD","LU1674673428.USD","BBH","LU0545039389.USD","BK4588","BK7067","LU0345770993.USD","LU0029864427.USD","IE000SO60NU8.SGD","LU0787776722.HKD","LU2592432038.USD","LU0472753341.HKD","LU0683600562.USD","LU1162221912.USD","LU0198837287.USD","LU0553294199.USD","LU0965508806.USD","LU2108987350.USD","LU0109391861.USD","LU0471298777.SGD","LU2237443382.USD","BK4550","LU0889566641.SGD","LU0345770308.USD","IE00BVYPNV92.GBP","ELIL","LU1914381329.SGD","LU2089984988.USD","PPH","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0130517989.USD","IYH","IE00B894F039.SGD","IE00BWXC8680.SGD","LLYX","LU0985320562.USD","04332","LU2896262040.SGD","SG9999014898.SGD","LU1066051498.USD","LU0225284248.USD","SG9999014567.USD","LU1066051225.USD","LU1035773651.USD","SG9999015341.SGD","LU1221951046.USD","BK4578","IE00BK4W5M84.HKD","LU1032955483.USD","LU2237443895.HKD","LU1116320737.USD","LU2462157665.USD","LU2129689431.USD","LU0203201768.USD","LU2487616109.SGD","LU1989771016.USD","LU0823434583.USD","LU0096364046.USD","LU1571399168.USD","LU2403377893.USD","BK4583","BK7511","LU0949170772.SGD","LU0210536198.USD","LU1201861249.SGD","LU0316494557.USD","SG9999017495.SGD","LU0266013472.USD","LU0256863811.USD","LU2089283258.USD","BK4516","LU2028103732.USD","IE0004445239.USD","GILD","LU0985481810.HKD","LU1839511570.USD","LU0689472784.USD","LU1267930813.SGD","ABBV","LU0211331839.USD","LU2746668974.SGD","LU1829250122.USD","LU0354030438.USD","LU2106854487.HKD","OZEM","LU1868837300.USD","LU0306806265.USD","LU1003077747.HKD","LU1732800096.USD","PBE","LU0353189763.USD","SG9999014880.SGD","IXJ","LU0889565916.HKD","LU2430703178.SGD","LU2750360641.GBP","LU2361044865.SGD","LU1093756168.USD","LU0070217475.USD","LU0069063385.USD","LU0353189680.USD","LU0070302665.USD","THNR","AGNG","IE00BSNM7G36.USD","LU0820561818.USD","LU2125154778.USD","LU0795875169.SGD","LU0158827948.USD","LU1228905540.USD","SG9999001440.SGD","IE00BKPKM429.USD","LU1894683264.USD","LU0823416689.USD","SG9999014906.USD","IE0009355771.USD","LU2471134952.CNY","BK4585","LU1934455277.USD","LU2471134796.USD","LU0323591593.USD","LU0310800379.SGD","LU1244550221.USD","LU2242652126.USD","LU1059921491.USD","LU2023251221.USD","LU0109394709.USD","SG9999018857.SGD","IE000BZT7R73.USD","LU2552382132.HKD","LU2168564149.EUR","CSL.AU","LU2236285917.USD","LU2133065610.SGD","LU1989772923.USD","SG9999018865.SGD","LU0289961442.SGD","LU2471134879.HKD","PAWZ","LU1989772840.SGD","IE00B7SZLL34.SGD","LU0130102774.USD","LU1074936037.SGD","LU2347655156.SGD","LU1551013342.USD","LU1043141123.HKD","IE00BJJMRX11.SGD","LU1670711123.USD","SG9999014575.USD","IE00B1BXHZ80.USD","LU0511384066.AUD","LU0225771236.USD","LU1037948541.HKD","MRK","IE00B4JS1V06.HKD","LU2462591350.SGD","LU0320765992.SGD","LU1267930490.SGD","ILDR","LU1929549753.HKD","LU0094547139.USD","SG9999014914.USD","LU0426412945.USD","LU1814569148.SGD","LU1037948897.HKD","LU0545562505.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0345769631.USD","JNJ","LU0321505868.SGD","LU0267386448.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391156","title":"Tango因季度虧損額超出預期而股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391156","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658391156?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:19","pubTimestamp":1786461555,"startTime":"0","endTime":"0","summary":"BUZZ-Tango因季度亏损额超出预期而股价下跌8月11日-** 药物研发公司Tango TherapeuticsTNGX.O股价下跌3.3%，报26.75美元** 据LSEG数据显示，该公司报告第二季度每股亏损37美分，而分析师平均预期为每股亏损31美分** TNGX报告称，截至2026年6月30日的三个月内未产生合作收入，原因是与吉利德GILD.O的合作关系及研发活动已终止** 该公司202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T44814U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU1674673691.USD","IE0002270589.USD","LU0320765992.SGD","LU1934455277.USD","IE0009355771.USD","RVMD","IBB","IE00B7SZLL34.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","BK4532","LU1066053197.SGD","BK4139","LU1934455863.HKD","TNGX","LU1674673428.USD","LU0965509010.AUD","LU0889565916.HKD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU2089984988.USD","IDNA","IE00B4R5TH58.HKD","LU2468319806.SGD","BIB","LU0114720955.EUR","BK4585","LU0289739699.SGD","LU2324357040.USD","LU0861579265.USD","LU1037948897.HKD","TBXU","PTH","LU0965508806.USD","LU1778281490.HKD","SG9999015952.SGD","TMED","BK4588","BMED","GILD","IBBQ","CANC","LU0234570918.USD","LU2087621335.USD","BBH","IE00BJJMRZ35.SGD","BK4583","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658196566","title":"百濟神州（06160）盤初漲3.94% 與安進聯合開發及商業化的安泰適正式投入臨床使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2658196566","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658196566?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 09:39","pubTimestamp":1786412383,"startTime":"0","endTime":"0","summary":"金吾财讯 | 百济神州 盘初上涨3.94%，最新报221.60港元，成交额1.86亿港元。消息面上，百济神州8月11日早上宣布，由百济神州与安进公司共同负责在中国开发和商业化的安泰适正式投入临床使用。此外，8月10日，百济神州宣布与Revolution Medicines达成一项多方面合作协议。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987884","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU1969619763.USD","LU0109394709.USD","BK1161","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","688235","PBE","LU0828237510.HKD","LU2112291526.USD","BK4533","LU0058720904.USD","LU0307460666.USD","LU2468319806.SGD","LU2089984988.USD","PJP","BK4588","IBB","LU1057294990.SGD","ONC","LU2242652126.USD","LU0289739699.SGD","LU1061106388.HKD","LU0228659784.USD","KURE","LU1770034418.SGD","SG9999001440.SGD","TBXU","BK1583","BK1500","BK4566","LU1983299246.USD","IE0002141913.USD","LU0588546209.SGD","BK4139","LU2242646821.SGD","BBH","BIB","BK4526","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","06160","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658930620","title":"美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658930620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658930620?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 23:39","pubTimestamp":1786376356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VRTX","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","IBBQ","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","PBE","IE00BZ9MQY76.HKD","LU2089984988.USD","BBH","BK4585","LU0289739699.SGD","IE0009355771.USD","LU2236285917.USD","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU2417539215.USD","SG9999013999.USD","BK4567","IE00B19Z9Z06.USD","LU1778281490.HKD","TBXU","BK4139","LU1093756168.USD","GNMX","LU2324357040.USD","LU2362541513.USD","SGXZ57979304.SGD","IDNA","LU1430594728.SGD","LU2456880835.USD","LU0417517546.SGD","LU1069344957.HKD","LU1674673428.USD","BK4588","SG9999001176.USD","LU2462157665.USD","SG9999001176.SGD","IBBJ","IE00B19Z9P08.USD","IE0002270589.USD","LU0234570918.USD","LU2362540622.SGD","IE0002141913.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":151,"code":"91000000","status":"200"}]}}